Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Nat Med ; 63(2): 124-9, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19050992

RESUMEN

The need for beneficial use of sedatives in oncologic patients is increasing. Therefore, in this study, antiproliferative characteristics of herbal and synthetic sedatives were examined in vitro in SNU-C4 human colorectal adenocarcinoma cells. Apigenin (50% inhibition concentration, IC(50) = 1.8 +/- 0.5 microM) and diazepam (IC(50) = 7.0 +/- 0.5 microM) showed concentration-dependent inhibition of SNU-C4 cancer cell survival. Efficacy of cancer cell survival inhibition by apigenin and diazepam was much lower than that of 5-fluorouracil (5-FU), a known chemotherapeutic drug. However, 10(-6) M concentration of apigenin and diazepam potentiated 5-FU-induced cytotoxicity. In SNU-C4 cells, 10(-6) M concentrations of diazepam, flumazenil (Ro15-1788), Ro5-4864, or PK11195, all ligands for central- or peripheral-type benzodiazepine (BZD) receptors, inhibited cell survival like the flavonoid apigenin (4',5,7-trihydroxyflavone) and fisetin (3,7,3',4'-tetrahydroxyflavone). Also like the plant flavonoids, treatment with 10(-6) M concentration of diazepam for 3 days hardly affect the peripheral-type BZD receptor (PBR) messenger RNA (mRNA) expression and inhibited glucose utilization of SNU-C4 cells. Treatment with flavonoids or diazepam for 6 days upregulated PBR mRNA expression and cell cytotoxicity of SNU-C4 cells. Furthermore, treatment with 10(-6) M concentration of apigenin, a natural sedative material originating from traditional herbs, positively modulated BZD-induced antiproliferative cytotoxicity in SNU-C4 cells. Overall, the in vitro antiproliferative activity on SNU-C4 cancer cells of herbal sedatives, such as apigenin, plus additive enhancement of synthetic BZD- and 5-FU-induced antiproliferative activities, were shown. In conclusion, this study provides experimental basis for advanced trial in the future.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Neoplasias Colorrectales/tratamiento farmacológico , Hipnóticos y Sedantes/farmacología , Adenocarcinoma/patología , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Apigenina/administración & dosificación , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Neoplasias Colorrectales/patología , Diazepam/administración & dosificación , Ensayos de Selección de Medicamentos Antitumorales , Sinergismo Farmacológico , Flavonoides/administración & dosificación , Flavonoles , Fluorouracilo/administración & dosificación , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Hipnóticos y Sedantes/administración & dosificación , Concentración 50 Inhibidora , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo
2.
Phytomedicine ; 14(2-3): 232-5, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16427264

RESUMEN

To investigate the putative mediation of peripheral benzodiazepine receptor (PBR) in the cytotoxicity of flavonoids, in this study, modulatory effects of several flavonoids on the lipid peroxide (LPO) production and PBR mRNA expression of human neuroblastoma cells were observed. Elevated levels of peroxidated products in cancer cells may activate pro-apoptotic and anti-proliferative signaling pathways. Treatment of 10(-6) M 4'-chlorodiazepam and PK 11195 ligands of the PBR for 6 days enhanced the generation of LPO of the human neuroblastoma cells. Several flavonoids, well-known cytotoxic substances, potentiated the enhancement of LPO production by PBR ligands. Treatment of 10(-6) M flavonoids for 6 days elevated the expression of PBR mRNA in cells. These findings indicate that the potential of flavonoids to induce apoptosis in cancer cells is strongly associated with their PBR-inducing properties, thereby providing a new mechanism by which polyphenolic compounds may exert their cancer-preventive and anti-neoplastic effects.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Benzodiazepinonas/metabolismo , Flavonoides/farmacología , Fitoterapia , Plantas Medicinales , Regulación hacia Arriba/efectos de los fármacos , Antineoplásicos Fitogénicos/administración & dosificación , Antineoplásicos Fitogénicos/uso terapéutico , Benzodiazepinonas/agonistas , Benzodiazepinonas/farmacología , Línea Celular Tumoral/efectos de los fármacos , Cartilla de ADN , Flavonoides/administración & dosificación , Flavonoides/uso terapéutico , Humanos , Peróxidos Lipídicos , Neuroblastoma/patología , ARN Mensajero/análisis , Receptores de GABA-A/genética , Receptores de GABA-A/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
3.
Toxicol Appl Pharmacol ; 209(3): 255-62, 2005 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-15936049

RESUMEN

The current study characterizes the mechanism by which the aqueous extract of Lycopus lucidus Turcz. (Labiatae) (LAE) decreases mast cell-mediated immediate-type allergic reaction. The immediate-type allergic reaction is involved in many allergic diseases such as asthma and allergic rhinitis. LAE has been used as a traditional medicine in Korea and is known to have an anti-inflammatory effect. However, its specific mechanism of action is still unknown. LAE was anally administered to mice for high and fast absorption. LAE inhibited compound 48/80-induced systemic reactions in mice. LAE decreased the local allergic reaction, passive cutaneous anaphylaxis, activated by anti-dinitrophenyl (DNP) IgE antibody. LAE dose-dependently reduced histamine release from rat peritoneal mast cells activated by compound 48/80 or anti-DNP IgE. Furthermore, LAE decreased the secretion of TNF-alpha and IL-6 in phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187-stimulated human mast cells. The inhibitory effect of LAE on the pro-inflammatory cytokine was p38 mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-kappaB) dependent. LAE attenuated PMA plus A23187-induced degradation of IkappaBalpha and nuclear translocation of NF-kappaB, and specifically blocked activation of p38 MAPK, but not that of c-jun N-terminal kinase and extracellular signal-regulated kinase. Our findings provide evidence that LAE inhibits mast cell-derived immediate-type allergic reactions and involvement of pro-inflammatory cytokines, p38 MAPK, and NF-kappaB in these effects.


Asunto(s)
Antialérgicos/farmacología , Lycopus/química , Mastocitos/efectos de los fármacos , Administración Rectal , Animales , Antialérgicos/administración & dosificación , Antialérgicos/uso terapéutico , Calcimicina/farmacología , Calcio/metabolismo , Línea Celular , Dinitrofenoles/administración & dosificación , Dinitrofenoles/toxicidad , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/metabolismo , Erupciones por Medicamentos/prevención & control , Hipersensibilidad a las Drogas/tratamiento farmacológico , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/metabolismo , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Liberación de Histamina/efectos de los fármacos , Humanos , Proteínas I-kappa B/metabolismo , Inyecciones Intraperitoneales , Interleucina-6/metabolismo , Masculino , Mastocitos/inmunología , Ratones , Ratones Endogámicos ICR , Inhibidor NF-kappaB alfa , FN-kappa B/metabolismo , Fitoterapia , Ratas , Ratas Sprague-Dawley , Acetato de Tetradecanoilforbol/análogos & derivados , Acetato de Tetradecanoilforbol/farmacología , Factor de Necrosis Tumoral alfa/metabolismo , p-Metoxi-N-metilfenetilamina/administración & dosificación , p-Metoxi-N-metilfenetilamina/toxicidad , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
4.
Biol Pharm Bull ; 27(4): 515-9, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15056857

RESUMEN

The present study was performed to evaluate the central nervous system inhibitory effects of the essential oil from SuHeXiang Wan (Storax pill), a prescription usually used for treating epilepsy in traditional Chinese medicine, on fragrance inhalation (aroma therapy). Preinhalation of the fragrance oil markedly delayed the appearance of pentylenetetrazole-induced convulsion, but showed weak activities on picrotoxin- and strychnine-induced convulsions, which implies this drug may inhibit the convulsion by GABAergic neuromodulation. This essential oil inhibited the binding of [(3)H]Ro15-1788, a selective antagonist for the benzodiazepine receptor and also the binding of [(3)H]flunitrazepam, a selective agonist for the receptor, in the presence of gamma-aminobutyric acid (GABA) and NaCl, showing a positive GABA shift, which suggested the strong possibility of the agonistic activity of the essential oil to the GABA/benzodiazepine receptor complex in rat cerebral cortices. Furthermore, inhalation inhibited the activity of GABA transaminase as the inhalation period was lengthened. The GABA level was significantly increased and glutamate content was significantly decreased in mouse brain by preinhalation of the essential oil. The above results suggest that the anticonvulsive effect of this essential oil can also originate from the enhancement of GABA level in the mouse brain, because convulsion depends partially on GABA concentration which can be properly preserved by inhibiting GABA transaminase. Fragrance inhalation progressively prolonged the pentobarbital-induced sleeping time as inhalation time was lengthened and inhibited brain lipid peroxidation, to which the anticonvulsive action is attributed; this also supported the above results, confirming the inhibitory effects of the essential oil of SuHeXiang Wan on the CNS via the GABAergic system.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Antioxidantes/uso terapéutico , Encéfalo/efectos de los fármacos , Medicamentos Herbarios Chinos/uso terapéutico , Aceites Volátiles/uso terapéutico , 4-Aminobutirato Transaminasa/antagonistas & inhibidores , Administración por Inhalación , Animales , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/farmacología , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Encéfalo/metabolismo , Encéfalo/fisiopatología , Química Encefálica/efectos de los fármacos , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/farmacología , Ácido Glutámico/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos ICR , Aceites Volátiles/administración & dosificación , Aceites Volátiles/farmacología , Pentilenotetrazol , Fitoterapia , Picrotoxina , Receptores de GABA-A/efectos de los fármacos , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Sueño/efectos de los fármacos , Estricnina
5.
Biol Pharm Bull ; 26(7): 978-82, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12843622

RESUMEN

The present study was designed to evaluate central inhibitory effects of the essential oil from Acori graminei Rhizoma (AGR), the dry rhizomes of Acorus gramineus SOLANDER (Araceae) upon fragrance inhalation (aroma therapy). Preinhalation of the oil markedly delayed the appearance of pentylenetetrazole-induced convulsion. Furthermore, inhalation impressively inhibited the activity of gamma-aminobutyric acid (GABA) transaminase, a degrading enzyme for GABA as the inhalation period was lengthened. The GABA level was significantly increased and glutamate content was significantly decreased in mouse brain by preinhalation of the essential oil. The above results suggest that the anticonvulsive effect of this AGR oil is originated by the enhancement of GABA level in the mouse brain, because convulsion depends partially on GABA concentration which can be properly preserved by inhibiting GABA transaminase. Moreover, fragrance inhalation progressively prolonged the pentobarbital-induced sleeping time as inhalation time was lengthened. Ten hour inhalation corresponded almost to the effect (145% increase) of oral administration (60 mg/kg). This sedative effect after inhalation or oral administration of AGR essential oil suggests that this oil may act on the CNS via the GABAergic system. The inhibitory activity of preinhalation of the essential oil on lipid peroxidation, to which the anticonvulsive action is attributed, also supported the above results, confirming and amplifying our previous reports on the CNS inhibitory effects of AGR.


Asunto(s)
Acorus , Sistema Nervioso Central/efectos de los fármacos , Inhibición Neural/efectos de los fármacos , Aceites Volátiles/administración & dosificación , Administración por Inhalación , Animales , Sistema Nervioso Central/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Inhibición Neural/fisiología , Aceites Volátiles/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Raíces de Plantas , Rizoma , Convulsiones/metabolismo , Convulsiones/prevención & control , Sueño/efectos de los fármacos , Sueño/fisiología
6.
Biol Pharm Bull ; 25(1): 128-30, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11824542

RESUMEN

Four sesquiterpenes, beta-selinene, isocurcumenol, nootkatone and aristolone and one triterpene, oleanolic acid were isolated from the ethylacetate fraction of the rhizomes of Cyperus rotundus and tested for their ability to modulate gamma-aminobutyric acid (GABA(A))-benzodiazepine receptor function by radioligand binding assays using rat cerebrocortical membranes. Among these compounds, only isocurcumenol, one of the newly identified constituents of this plant, was found to inhibit [3H]Ro15-1788 binding and enhance [3H]flunitrazepam binding in the presence of GABA. These results suggest that isocurcumenol may serve as a benzodiazepine receptor agonist and allosterically modulate GABAergic neurotransmission via enhancement of endogenous receptor ligand binding.


Asunto(s)
Cyperaceae/química , Moduladores del GABA/farmacología , Receptores de GABA-A/efectos de los fármacos , Sesquiterpenos/farmacología , Animales , Unión Competitiva/efectos de los fármacos , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Flumazenil/metabolismo , Flunitrazepam/metabolismo , Moduladores del GABA/aislamiento & purificación , Técnicas In Vitro , Masculino , Extractos Vegetales/química , Extractos Vegetales/farmacología , Raíces de Plantas/química , Ensayo de Unión Radioligante , Ratas , Ratas Sprague-Dawley , Sesquiterpenos/química , Sesquiterpenos/aislamiento & purificación , Ácido gamma-Aminobutírico/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA